Cilostazol systems

USP DI Editorial Group. C Monographs Cilostazol (Systemic). In USP DI Drug Information for the Health Care Professional. 24th ed. Taunton, Massachusetts Micromedex Inc. 2004. 

CYP450 system Anagrelide enhanced the inhibition of platelet aggregation by aspirin and is an inhibitor of cyclic AMP PDE III (may exaggerate the properties of milrinone, enoximone, amrinone, olprinone, and cilostazol). 

P450 system Drugs that may be affected by proton pump inhibitors include benzodiazepines, clarithromycin, cyclosporine, disulfiram, digoxin, azole antifungal agents, hydantoins, cilostazol, salicylates, sulfonylureas, and warfarin. 

Mahmoud, D.B., Shukr, M.H., Bendas, E.R., 2014. In vitro and in vivo evaluation of self-nanoemulsifying drug delivery systems of cilostazol for oral and parenteral administration. Int. J. Pharm. 476, 60—69. 

Kang SY, Kim JY, Kim MY, Lee SY, Kim MH, Kim TW, et al. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms syndrome induced by cilostazol and carbamazepine. J Dermatol August 2012 39(8) 723-4. 

---